Denmark has announced that it doesn't need the AstraZeneca COVID-19 vaccine and has removed it from its vaccination programme, CNN news website reported on Wednesday.
The Danish Health Authority has stated that the AstraZeneca vaccine is not needed because Denmark has already reached "such an advanced point" in its vaccine rollout. It added that all booked vaccines from AstraZeneca would be cancelled.
Director General of the Danish Health Authority, Søren Brostrøm, was quoted as saying: "We are basically in agreement with EMA's assessment regarding the AstraZeneca vaccine. That is why it is important to emphasise that it is still an approved vaccine [in Europe]. And I understand if other countries in a different situation than us choose to continue using the vaccine."
The use of AstraZeneca was paused on 11 March 2021, but the Danish vaccination effort has continued with the vaccines from Pfizer/BioNTech and Moderna. The country has now vaccinated 1,000,000 Danes.
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
Precision Epigenomics partners with TruDiagnostic
Illumina's GRAIL divestment plan receives EC approval
Soligenix receives orphan drug designation from FDA for active ingredient in SuVax
Candel Therapeutics granted FDA Orphan Drug Designation for CAN-2409 in pancreatic cancer treatment
Lipogems completes patient enrolment in ARISE I US FDA IDE study
Amylyx Pharmaceuticals' AMX0035 shows promising impact on Wolfram syndrome symptoms
Ondine Biomedical's Steriwave approved for use by HCA UK
Roche attains CE Mark for first companion diagnostic for HER2-low metastatic breast cancer
Cadrenal Therapeutics' tecarfarin receives US FDA Orphan Drug Designation
BioCity Biopharma's BC2027 Phase one study IND application receives US FDA approval
Seres Therapeutics completes patient enrollment for SER-155 Phase 1B trial
Syros receives Fast Track Designation from FDA for tamibarotene in AML